| 2020 |
Woods GN, Ewing SK, Sigurdsson S, Kado DM, Eiriksdottir G, Gudnason V, Hue TF, Lang TF, Vittinghoff E, Harris TB, Rosen C, Xu K, Li X, Schwartz AV. Greater bone marrow adiposity predicts bone loss in older women. J Bone Miner Res. February 2020;35(2):326-332. |
3 |
2 |
| 2020 |
Napoli N, Conte C, Eastell R, Ewing SK, Bauer DC, Strotmeyer ES, Black DM, Samelson EJ, Vittinghoff E, Schwartz AV. Bone turnover markers do not predict fracture risk in Type 2 diabetes. J Bone Miner Res. December 2020;35(12):2363-2371. |
3 |
1 |
| 2022 |
Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T, Takeuchi Y, Schafer AL, Kim TY, Cauley JA. The interaction of acute-phase reaction and efficacy for osteoporosis after zoledronic acid: HORIZON pivotal fracture trial. J Bone Miner Res. January 2022;37(1):21-28. |
1 |
1 |
| 2022 |
Dhaliwal R, Ewing SK, Vashishth D, Semba RD, Schwartz AV. Greater carboxy-methyl-lysine is associated with increased fracture risk in type 2 diabetes. J Bone Miner Res. February 2022;37(2):265-272. |
7 |
6 |
| 2022 |
Woods GN, Ewing SK, Schafer AL, Gudnason V, Sigurdsson S, Lang T, Hue TF, Kado DM, Vittinghoff E, Rosen C, Li X, Schwartz AV. Saturated and unsaturated bone marrow lipids have distinct effects on bone density and fracture risk in older adults. J Bone Miner Res. April 2022;37(4):700-710. |
1 |
0 |
| 2022 |
Babey ME, Ewing SK, Strotmeyer ES, Napoli N, Schafer AL, Vittinghoff E, Gundberg CM, Schwartz AV. No evidence of association between undercarboxylated osteocalcin and incident type 2 diabetes. J Bone Miner Res. May 2022;37(5):876-884. |
1 |
1 |
| 2022 |
Eastell R, Vittinghoff E, Lui L-Y, Ewing SK, Schwartz AV, Bauer DC, Black DM, Bouxsein ML. Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. J Bone Miner Res. November 2022;37(11):2121-2131. |
0 |
0 |